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Abstract
Background: To determine the dynamic range and the maximum output of three current middle ear implants and to discuss 
optimal candidacy for middle ear implantation.
Study Design: Clinical study.
Material and Methods: Gain and output measurements were compared for three types of middle ear implants: the Otologics 
middle ear transducer (MET), the Vibrant Soundbridge (VSB), and the Direct Acoustic Cochlear Stimulator (DACS). The per-
formance of these selected implants in users with severe, predominantly sensorineural, hearing loss (50–65 dB HL) was stud-
ied. Patients with chronic external otitis and sensorineural hearing loss used either a MET (n=9) or a VSB (n=9) implant. Pa-
tients with a predominantly sensorineural hearing loss after surgically treated otosclerosis used a DACS (n=4). Patients were 
selected from two different implant teams but evaluated with the same protocol. The relative gain at threshold level was deter-
mined, viz. the bone-conduction threshold minus the aided soundfield threshold, divided by the bone-conduction threshold. 
Input–output measurements were performed with the devices in linear amplification mode and with unlimited output. In this 
latter data set, the maximum output and the input dynamic range of the devices were determined.
Results: The relative gain for each of the three implants was comparable; however, the values were slightly lower than the gen-
erally accepted target values. The input dynamic range of the devices varied, with the widest range for the DACS and Oto-
logics devices.
Conclusion: The results from this study indicate that the first generation DACS device is a good option for patients with mod-
erate/severe sensorineural hearing loss and surgically treated otosclerosis who require a hearing implant.
Key words: middle ear implants • implantable hearing aids • otologics MET • Vibrant Soundbridge • VSB • DACS • dynam-
ic range
MEJORA Y SALIDA MÁXIMA DE DISPOSITIVOS AUDITIVOS IMPLANTABLES EN 
PACIENTES CON MODERADA A SEVERA PÉRDIDA AUDITIVA NEUROSENSORIAL
Extracto
Antecedentes: Determinar el rango dinámico y la salida máxima de tres implantes actuales del oído medio y analizar la can-
didatura óptima para la implantación del oído medio.
Diseño del Estudio: Estudio clínico.
Material y Métodos: Se compararon las mediciones de beneficio y salida de tres tipos de implantes del oído medio: el transductor 
de oído medio de Otologics (MET), Vibrant Soundbridge (VSB), y el Estimulador Directo Acústico de Cóclea (DACS). Se estu-
dió la salida de estos implantes seleccionados en usuarios con grave pérdida de la audición, predominantemente neurosensorial 
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Background
Several types of implantable hearing systems, or active 
middle ear implants (AMEI), have been introduced over 
the last two decades. In 1996, the Vibrant Soundbridge 
(VSB, Med-El, Innsbruck, Austria) became available for 
(50–65 dB HL). Los pacientes con otitis externa crónica y pérdida de audición neurosensorial utilizaron el implante MET (n=9) 
o VSB (n=9). Los pacientes con una pérdida auditiva predominantemente neurosensorial después del tratamiento quirúrgico 
de otosclerosis utilizaron DACS (n=4). Los pacientes fueron seleccionados de dos equipos diferentes de implantes pero fueron 
evaluados utilizando el mismo protocolo. Se determinó la mejora relativa en el nivel umbral, a saber, el umbral de conducción 
ósea menos el umbral de campo de sonido asistido, dividido por el umbral de conducción ósea. Las mediciones de entrada-
salida se realizaron con los dispositivos en modo de amplificación lineal y con la salida ilimitada. En este último conjunto de 
datos, se determinó la salida máxima y el rango dinámico de entrada de los dispositivos.
Resultados: El beneficio relativo para cada uno de los tres implantes fue comparable, sin embargo, los resultados fueron lige-
ramente inferiores que los valores objetivo generalmente aceptados. El rango dinámico de entrada de los dispositivos varió, el 
rango más amplio siendo él de dispositivos DACS y Otologics.
Conclusión: Los resultados de este estudio indican que la primera generación del dispositivo DACS es una buena opción para 
los pacientes con moderada / severa pérdida auditiva neurosensorial y otosclerosis tratada quirúrgicamente que requieren un 
implante auditivo.
Palabras claves: implantes de oído medio • audífonos implantables • otologics MET • Vibrant Soundbridge • VSB • DACS • 
rango dinámico
УСИЛЕНИЕ И МАКСИМАЛЬНАЯ МОЩНОСТЬ ВЖИВЛЯЕМЫХ 
СЛУХОВЫХ УСТРОЙСТВ У ПАЦИЕНТОВ С УМЕРЕННОЙ И ТЯЖЕЛОЙ 
СЕНСОНЕЙРОННОЙ ПОТЕРЕЙ СЛУХА
Резюме
Предпосылки: Определить динамический диапазон и максимальную мощность трех современных имплантов 
среднего уха и обсудить оптимальных кандидатов на импланты среднего уха.
Испытания: Клинические испытания.
Материалы и Mетоды: Сопоставленны измерения усиления и мощности трех типов имплантов среднего уха: 
отологический трансдьюсер среднего уха (MET), имплант Vibrant Soundbridge (VSB) и непосредственный аку-
стический кохлеарный стимулятор (DACS). Мы исследовали дейтвие этих выбраных имплантов главным обра-
зом у пользователей с тяжелой сенсонейронной потерей слуха (50–65 дБ HL). Пациенты с хроническим наруж-
ным отитом и сенсонейронной потерей слуха пользовались имплантом MET (n=9) либо VSB (n=9). Пациенты 
в основном с сенсонейронной потерей слуха после леченного операционным путем отосклероза пользовались 
имплантом DACS (n=4). Пациенты были выбраны из двух разных имплантных команд, но они оценивались 
по тому самому протоколу. Определено соответственное усиление порогового уровня, а именно порог кост-
ной проводимости минус порог звукового поля со вспомоганием разделенный порогом костной проводимости. 
Входные- выходные измерения произведены с помощью устройств в линейном усиленном режиме и с неогра-
ниченной мощностью. В этом последнем составе данных определена максимальная мощность и динамический 
входной диапазон устройств.
Результаты: Cоответсвенная мощность каждого из трех имплантов – сравнимая; однако, значения были нем-
ного ниже, чем общепринятые заданные значения. Динамический входной диапазон устройств изменялся, при 
чем самый широкий диапазон имели импланты DACS и Otologics.
Заключение: Итоги этих исследований показывают, что аппарат первой генерации DACS - это хорошая воз-
можность для пациентов с умеренной/тяжелой сенсонейронной потерей слуха и леченным хирургическим пу-
тем отосклерозом, которые требуют слухового импланта.
Ключевые слова: импланты среднего уха • вживляемые слуховые аппараты • Otologics MET • Vibrant Soundbridge 
• VSB • DACS • динамический диапазон
clinical evaluation [1], and this was followed by the Oto-
logics Middle Ear Transducer (MET, Otologics LLC, Boul-
der, CO, USA). These semi-implantable devices have been 
successfully applied in patients with sensorineural hear-
ing loss [2–4]. These devices typically consist of an actu-
ator directly coupled to the ossicular chain and driven 
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Figure 1.  Mean bone-conduction thresholds plotted as 
a function of frequency for three groups of 
middle ear implant users: patients using the 
Vibrant Soundbridge (VSB), the Otologics MET 
(MET), and the DACS. Vertical bars are standard 
deviations.
by an external audio processor [5]. More recently, mid-
dle ear implants have also been used in patients with oto-
sclerosis [6–9].
The Direct Acoustic Cochlear Stimulator (DACS) device, 
introduced in 2006, is a version of a semi-implantable mid-
dle ear implant that bypasses the outer and middle ear struc-
tures and directly stimulates the cochlea [10,11]. The DACS 
has been used in a feasibility study of patients with mod-
erate/severe sensorineural hearing loss due to otosclerosis.
The DACS system is an actively-driven stapes prosthesis; 
an electromagnetic actuator is implanted in the mastoid 
cavity and connected to a conventional stapes prosthesis, 
which directly drives inner ear fluid movement. The ex-
ternal audio processor is connected to the actuator by a 
percutaneous plug. In the first DACS study, the ossicu-
lar chain was reconstructed during the implantation sur-
gery by inserting an additional, passive stapes prosthesis 
[11]. This surgery reduced the air-bone gap and postop-
eratively left a predominantly sensorineural hearing loss 
for the patients.
Traditionally, to measure the gain and output of conven-
tional hearing devices, artificial simulators are used. For 
middle ear implants, such simulators are not available; 
therefore, the basic amplification characteristics are typi-
cally measured in patients. For example, to measure gain, 
the functional gain (FG) can be determined by subtract-
ing the aided sound field thresholds from the unaided 
sound field thresholds. However, measuring FG can be 
problematic when used on middle ear implant devices 
for three reasons. First, if an air-bone gap is present af-
ter surgery, this will raise the unaided threshold propor-
tionally and will overestimate the FG. The measured FG 
will then be the sum of the pure device gain plus the post-
surgery air-bone gap. Second, noise-reduction algorithms, 
which are often present in current hearing devices in-
cluding middle ear implants, can interpret test signals as 
noise and consequently reduce amplification. Finally, the 
middle ear implants studied here make use of adaptive, 
non-linear amplification. Therefore, sound field thresh-
old measurements evaluate the (relatively high) gain for 
soft sounds and overestimate the gain for conversation-
al speech levels [12].
An additional amplification characteristic is the saturation 
(SAT) level of the device, which is the loudest input sound 
that can be properly processed by the device. The input 
level at the point of saturation can be measured by stud-
ying the output behavior of the device. Previous research 
has shown that it is possible to measure output limitations 
objectively with a microphone placed in the ear canal. In 
the current study, we have compared the basic capacities 
of three implantable hearing systems. The gain of the de-
vices was compared in matched patient groups. In addi-
tion, the dynamic range and maximum output of the three 
devices were determined while the devices were in linear 
amplification mode with unlimited output. The results of 
this study are used to discuss optimal candidacy for mid-
dle ear implants.
Material and Methods
Patients
All data were acquired from patients who used a (unilater-
al) middle ear implant: four DACS users (the only patients 
with the first generation DACS as described by Hausler et 
al. [11]); nine VSB users selected from the Nijmegen data-
base of 55 VSB users; and nine MET users, selected from 
the same database of 18 MET users. VSB and MET users 
were matched with the DACS users based on the degree 
of preoperative sensorineural hearing loss (criteria: bone-
conduction thresholds between 30 and 60 dB HL at 500 
Hz and between 50 and 75 dB HL at 4 kHz and a mean 
hearing loss of between 50 and 65 dB HL at 0.5, 1, 2, and 
4 kHz) and the length of device use (minimum of 1 year).
Figure 1 shows the mean preoperative bone-conduction 
thresholds of the implanted ear in patients from each 
group. The VSB and MET users had been provided with 
implants due to therapy-resistant chronic external otitis. 
These patients had a predominantly sensorineural hearing 
loss, although an air-bone gap in the order of 5–10 dB was 
common. Prior to treatment, the DACS patients showed 
both sensorineural and conductive hearing loss caused by 
otosclerosis. At the DACS post-operative evaluation, the 
air-bone gap had been reduced because the fixed stapes 
had been replaced by a secondary, passive stapes prosthe-
sis [11]. A mean air-bone gap of 14 dB remained at 0.5, 1, 
2, and 4 kHz (range 6–20 dB).
The VSB users were fitted with the 404 audio processor 
(Med-El, Innsbruck, Austria); the MET users were fitted 
with the Button processor (Otologics LLC, Boulder, CO, 
USA); and the DACS users were fitted with the Savia 211 
processor (Phonak, Staefa, Switzerland). All fittings were 
done by experienced audiologists.
Parameters
The two parameters used in this study are an FG-based 
gain ratio (GR) and the input level at output saturation 
(ILS) [13].
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Gain ratio (GR)
The bone conduction, based on the functional gain at the 
threshold level, was defined as the difference between the 
bone-conduction threshold and the aided threshold. This 
value, divided by the bone-conduction threshold, was called 
the gain ratio (GR) and was calculated for each frequen-
cy. The GR at each frequency can be compared with target 
values, as produced by prescription rules. According to the 
commonly used NAL-NL prescription rule, for conversa-
tional levels, the GR should be 0.46; this indicates that the 
desired FG should be approximately 0.46 times the hear-
ing threshold (at 1–4 kHz) [14]. For softer sounds, ratios 
higher than 0.46 are prescribed [15]. These reference ratios 
can be used to assess the adequacy of amplification provid-
ed by the middle ear implant. This ratio is independent of 
the patient’s degree of hearing loss, unlike the FG. To de-
termine the GR, noise-reduction algorithms were deacti-
vated. All other settings were the patient’s daily settings.
Input level at output saturation (ILS)
To determine the input level at saturation for the three im-
plant devices, the procedure described by Snik et al. was 
followed [13]. Briefly, sound pressure levels were measured 
with the Aurical REM system in the ear canal of the aid-
ed ear (Madsen, Taastrup, Denmark). Measurements were 
conducted while the ear canal was occluded with an EAR-
link foam tip (Aearo Company, Indianapolis, IN, USA). 
After a foam tip was inserted, a probe tube microphone 
was pushed through the standard opening in the plug. In 
this manner, the sound pressure level could be measured 
in the occluded ear canal. Sound pressure levels were re-
corded as a function of frequency during the presentation 
of a calibrated frequency sweep produced in the sound field 
(sweep from 250 Hz to 8 kHz at 60 dB SPL, as standard 
on the Aurical REM system). The first measurement was 
carried out with the audio processor off (reference curve), 
and the measurement was repeated with the audio proces-
sor on. The difference curve was used for further analysis. 
Similar curves were obtained at 50, 70, 80, and 90 dB SPL. 
From the difference curves, the input level at which the de-
vice saturated was determined at 1 kHz and 2 kHz. Figure 
2 shows representative data. Output limiting options were 
deactivated, and the device was programmed in the linear 
amplification mode.
To measure sound field thresholds, warble tones were pre-
sented via a loudspeaker placed 1 m in front of the patient 
and calibrated according to Morgan et al. [16].
Nine of the 22 patients participated in a special session to 
measure the output limitation of the devices (three MET 
users, four VSB users, and two DACS users). These patients 
were randomly selected. The measurements were carried 
out in sound-proof double-walled rooms.
Results
The GR as a function of frequency is presented in Figure 3. 
The mean data are presented separately for the matched 
VSB, MET, and DACS users. Vertical lines indicate stand-
ard deviations.
A representative example of an input–output measurement, as 
derived from sound-pressure measurements in the occluded 
ear canal, is presented in Figure 2. After turning the device 
on, there was an increase of 15–20 dB SPL at 1 to 3 kHz in 
the ear canal. The data in Figure 2 are from a patient using a 
DACS device. These data have a linear increase until the out-
put levels-off at an input level of 75 dB SPL at 1 kHz and 80 
dB SPL at 2 kHz. In a second patient with a DACS, the input 
level at saturation was above 80 dB SPL; this patient could 
not tolerate stimulation louder than 80 dB SPL. For the oth-
er two implant systems, the output saturated at lower input 
levels. Figure 4 shows the maximum dynamic range of the 
three devices, which is defined as the difference between the 
input level at saturation and the aided thresholds, expressed 
in dB SPL, and obtained in the linear amplification mode.
Discussion
In contrast to studies that assess individual benefit and 
satisfaction levels, the measurements in the current study 
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Figure 3.  Functional gain at threshold level divided by 
bone-conduction threshold versus frequency 
for three groups of middle ear implant users: 
patients using the Vibrant Soundbridge (VSB), 
the Otologics MET (MET), and the DACS. Mean 
values are displayed with standard deviations.
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Figure 2.  Input–output curves at 1 kHz and 2 kHz obtained 
from probe-tube microphone measurements in 
the ear canal of a patient with a DACS device. The 
arrows indicate the level of device saturation.
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Figure 4.  Hearing thresholds (stripes), input level at satu-
ration (grey), and dynamic range (cross-hatch) 
for the three groups of patients as measured at 
1 kHz (left columns) and 2 kHz (right columns). 
Mean data with ranges are presented. The au-
dio processors were programmed in linear am-
plification mode and the maximum output was 
not limited.
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are device-specific, not patient-specific dynamic range and 
maximum output, and are therefore helpful when com-
paring systems. While previous studies addressed benefit 
measures, such as speech perception and patient opinions, 
this study investigated the basic performance of three ac-
tive, semi-implantable middle ear devices used in patients 
matched according to the extent of their sensorineural 
hearing loss. Previously, it has been shown that the gain 
(amplification) and maximum output are important pa-
rameters in evaluating the basic operation of implantable 
hearing systems [13,17].
Figure 3 shows the gain ratio (GR), a measure that is, in 
principle, hearing-loss independent and can therefore be 
averaged over patients. Significant differences between the 
three devices were not found (t-test, p>0.05). This result 
is not surprising because the actual gain is determined by 
the user, either by adjusting the volume (MET and DACS), 
or, if volume control is absent, by adjustments made dur-
ing the device fitting. The desired gain ratio, according to 
the NAL rule, should be at least 0.46 (at 1, 2, and 4 kHz). 
This GR was found at 1 kHz and 2 kHz for the DACS us-
ers and at 2 kHz for the VSB users; for MET users, the 
values at 1 kHz and 2 kHz approached this target value. 
A target ratio of 0.46, as prescribed by the NAL rule, was 
matched but not surpassed by the three systems [14,15].
As shown by Snik et al., the proper processing of loud sounds 
by the implant can be measured objectively with a probe mi-
crophone in the ear canal [13]. The probe measures the vi-
brations produced by the actuator of the middle ear implant 
because these reach not only the cochlea but also the tym-
panic membrane. The probe thus measures the vibrations 
produced as a by-product. Although such measurements 
cannot be used to assess gain, they can be used to study the 
input–output behavior of middle ear implants [13]. Meas-
uring input–output behavior was possible with the VSB, the 
MET, and the DACS ( Figure 2). The input level at satura-
tion was higher for the DACS than for the MET or VSB. As 
a consequence, the dynamic range was the widest for the 
DACS (see Figure 4). These data can, in part, be attributed 
to the percutaneous coupling between the actuator and au-
dio processor, which may be more effective than the contact-
free, radio-frequency coupling in the VSB and MET [18].
The individual (dynamic) hearing range of a patient can be 
determined from audiograms as the difference between the 
hearing thresholds and the loudness discomfort levels, or 
UCL [14]. For patients with a sensorineural hearing loss of 
50–65 dB HL, the dynamic hearing range is in the order of 
50–60 dB [19]. The DACS device best approaches this value 
(Figure 4). When the dynamic range of a hearing device is 
less than the patient’s hearing range, patients may choose 
to lower the gain to widen the dynamic range and prevent 
the distortion of loud sounds, such as from their own voice, 
due to device saturation. This may explain why the ampli-
fication results for the VSB and MET are slightly, although 
not significantly, lower than those for the DACS (Figure 3).
Figure 4 shows that, for each device type, particularly for 
the VSB versus the DACS, the range of input level at sat-
uration minimally overlapped, suggesting that differenc-
es between the devices are important.
A limitation of the present study is the small number of 
patients in the maximum output measurements. Howev-
er, in the present protocol these measurements are not 
patient-specific, but device-specific, so subjective patient 
factors are avoided.
Compared to the implantation of the VSB and the MET, 
the DACS surgery is more invasive because the vestibulum 
is entered and this can lead to damage. The risk of coch-
lear damage in the DACS surgical procedure is thought 
to be comparable to that of a classical stapedotomy be-
cause a standard stapes prosthesis is used [11]. Further-
more, the DACS system was designed to be used only in 
patients with mixed hearing loss caused by otosclerosis.
Conclusion
The results of the present study suggest that the percuta-
neous DACS middle ear implant has a amplification ca-
pacity that exceeds the VSB and has a comparable or bet-
ter capacity than the Otologics MET middle ear implant; 
because of this larger dynamic range it can therefore be 
of assistance in patients with moderate to severe sensori-
neural hearing loss.
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